Stef Meers
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 11
- Hematopoietic Stem Cell Transplantation 3
- Genetics 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Gregor Verhoef (5 shared papers)Koen Theunissen (5 shared papers)Johan Maertens (2 shared papers)Johan Van Eldere (2 shared papers)Katrien Lagrou (2 shared papers)Wouter Meersseman (2 shared papers)Philippe Meersseman (1 shared paper)Eric Verbeken (1 shared paper)
- Journals
- Clinical Infectious Diseases (2 papers)European Journal Of Haematology (2 papers)Blood (2 papers)Leukemia Research (1 paper)Leukemia (1 paper)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Stef Meers
20 papers receiving 412 citations
Peers
Comparison fields: 5 of 53
- Infectious Diseases 175
- Hematology 103
- Parasitology 52
- Epidemiology 218
- Transplantation 15
Countries citing papers authored by Stef Meers
This map shows the geographic impact of Stef Meers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stef Meers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stef Meers more than expected).
Fields of papers citing papers by Stef Meers
This network shows the impact of papers produced by Stef Meers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stef Meers. The network helps show where Stef Meers may publish in the future.
Co-authors
The 25 scholars most cited alongside Stef Meers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 182 | |
| 2 | 2010 | 53 | |
| 3 | 2023 | 36 | |
| 4 | 2018 | 31 | |
| 5 | 2007 | 18 | |
| 6 | 2007 | 15 | |
| 7 | 2010 | 12 | |
| 8 | 2022 | 11 | |
| 9 | 2010 | 10 | |
| 10 | 2014 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2014 | 7 | |
| 13 | 2011 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 5-aza-2 '-deoxycytidine can induce differentiation of clonal abnormal progenitor cells from patients with myelodysplastic syndromes without induction of apoptosis | 2008 | 4 |
| 16 | 2019 | 3 | |
| 17 | 2018 | 3 | |
| 18 | 2013 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2014 | 1 |
About Stef Meers
Stef Meers is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Immunology and Epidemiology, having authored 22 papers that have together received 416 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Complement system in diseases (2 papers), CAR-T cell therapy research (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Infectious Diseases (175 citations), Hematology (103 citations), Parasitology (52 citations), Epidemiology (218 citations) and Transplantation (15 citations). Stef Meers has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Gregor Verhoef, Koen Theunissen, Johan Maertens, Johan Van Eldere, Katrien Lagrou, Wouter Meersseman, Philippe Meersseman, Eric Verbeken, Timothy Devos and Daan Dierickx. Their work appears in journals such as Clinical Infectious Diseases, European Journal Of Haematology, Blood, Leukemia Research and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.